Answers are grounded in this paper and cite their sources.
Pilot study demonstrates improved PET imaging for metastatic lesions in brain and breast, suggesting implications for staging and prognosis.
[⁶⁸Ga]Ga-RM2 PET/CT demonstrates superior uptake metrics for the detection of metastatic lesions, particularly in the brain and breast, suggesting its potential as a valuable complementary imaging modality to [¹⁸F]FDG PET/CT. These promising foundings warrant further validation in larger cohorts to confirm their clinical impact and to standardize imaging protocols.
No takes yet. Share an insight, caveat, or question.
Ding et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: